acetaminophen and s 1743

acetaminophen has been researched along with s 1743 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Anneveld, B; de Koning, BA; de Wildt, SN; Hanff, LM; Havenaar, R; Lelieveld, JP; Minekus, M; Mooij, MG1
Bartoli, F; Blagojevic, J; Bruni, C; Cometi, L; Fiori, G; Furst, DE; Galluccio, F; Matucci Cerinic, M; Tofani, L1
Li, PH1

Trials

1 trial(s) available for acetaminophen and s 1743

ArticleYear
In vitro gastrointestinal model (TIM) with predictive power, even for infants and children?
    International journal of pharmaceutics, 2013, Nov-30, Volume: 457, Issue:1

    Topics: Acetaminophen; Biological Availability; Child; Diclofenac; Esomeprazole; Gastrointestinal Tract; Humans; Infant; Infant, Newborn; Models, Biological

2013

Other Studies

2 other study(ies) available for acetaminophen and s 1743

ArticleYear
Premedication prevents infusion reactions and improves retention rate during infliximab treatment.
    Clinical rheumatology, 2016, Volume: 35, Issue:11

    Topics: Acetaminophen; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Chlorpheniramine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Esomeprazole; Female; Humans; Hydrocortisone; Hydroxyzine; Infliximab; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Premedication; Ranitidine; Retrospective Studies; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha

2016
Skin testing for hypersensitivity and cross-reactivity between proton pump inhibitors.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2020, Volume: 26, Issue:5

    Topics: Acetaminophen; Adult; Cross Reactions; Diagnosis, Differential; Drug Hypersensitivity; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Humans; Proton Pump Inhibitors; Skin Tests

2020